We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: Hypertension
MedXY News
EnglishTag

Hypertension

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Global Disparities in Heart Failure: Incidence and Mortality Across Income Levels and Regions
Cardiologyepidemiologyglobal health

Global Disparities in Heart Failure: Incidence and Mortality Across Income Levels and Regions

By MedXY|Apr 28, 2026

The PURE study reveals significant global disparities in heart failure incidence and mortality, with hypertension as the leading modifiable risk factor, highlighting the need for targeted prevention and treatment strategies.

Shear Stress-Induced Endothelial HEG1 Signalling: A Novel Pathway Linking Blood Flow to Blood Pressure Regulation
Cardiologyblood pressureendothelial dysfunction

Shear Stress-Induced Endothelial HEG1 Signalling: A Novel Pathway Linking Blood Flow to Blood Pressure Regulation

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
By MedXY|Apr 17, 2026

Researchers identify HEG1 as a critical flow-sensitive endothelial protein that regulates blood pressure through CUL3-mediated degradation of PHACTR1, linking reduced shear stress in hypertension to impaired NO production and vascular dysfu

Even ‘Elevated’ Blood Pressure Raises Dementia Risk: Insights from 2.8 Million Adults Over 8 Years
Cardiologyblood pressurecardiovascular risk

Even ‘Elevated’ Blood Pressure Raises Dementia Risk: Insights from 2.8 Million Adults Over 8 Years

By MedXY|Apr 15, 2026

A landmark South Korean study of 2.8 million adults reveals that both elevated blood pressure and hypertension significantly increase dementia risk, particularly vascular dementia, with stronger effects observed in midlife adults and women.

Why Exercise Blood Pressure Alone May Miss Cardiovascular Risk—and What Combining It With Fitness Reveals
Cardiologyaerobic fitnesscardiovascular risk

Why Exercise Blood Pressure Alone May Miss Cardiovascular Risk—and What Combining It With Fitness Reveals

By MedXY|Apr 13, 2026

The EXERTION study of 12,743 individuals demonstrates that exercise systolic blood pressure relative to aerobic fitness (SBP/METPeak) is a powerful predictor of cardiovascular events, whereas exercise BP alone provides no prognostic value.

Mobile Health Intervention Achieves 24% Better Blood Pressure Control in Stroke Survivors: PINGS Trial Results from Ghana
CardiologyBlood Pressure ControlHypertension

Mobile Health Intervention Achieves 24% Better Blood Pressure Control in Stroke Survivors: PINGS Trial Results from Ghana

By MedXY|Apr 13, 2026

The PINGS trial demonstrates that a 12-month nurse-led mobile health intervention significantly improves blood pressure control among Ghanaian stroke survivors, with 67% achieving target BP versus 43% in usual care. This pragmatic approach

Redefining the Renin-Aldosterone Axis: From Categorical Diagnosis to a Continuous Spectrum of Cardiorenal Risk
Cardiologycardiorenal syndromeHypertension

Redefining the Renin-Aldosterone Axis: From Categorical Diagnosis to a Continuous Spectrum of Cardiorenal Risk

By MedXY|Apr 5, 2026

This article synthesizes evidence from a 2026 Danish nationwide cohort and supporting literature, illustrating that renin-independent aldosterone production represents a continuous risk gradient for kidney failure and MACE, even below tradi

Deciphering the Clinician’s Dilemma: Determinants of Antihypertensive Treatment Intensification in Older Adults
CardiologyClinical Inertiadigital health

Deciphering the Clinician’s Dilemma: Determinants of Antihypertensive Treatment Intensification in Older Adults

By MedXY|Apr 2, 2026

This review analyzes the complex factors influencing blood pressure management in older adults, highlighting how age, frailty, and digital health data shape clinician decisions and clinical inertia.

Patient Engagement and the Reality of Home Blood Pressure Monitoring: New Research Perspectives
CardiologyCardiologydigital health

Patient Engagement and the Reality of Home Blood Pressure Monitoring: New Research Perspectives

By MedXY|Mar 20, 2026

This study examines patient engagement with home blood pressure monitoring (HBPM) in a remote management program, revealing that accessibility and support do not always guarantee high patient compliance.

Relacorilant Demonstrates Sustained Efficacy in Hypertension Control for Patients with Cushing’s Syndrome: Results from the Phase 3 GRACE Study
Diabetes & EndocrinologyCushing's SyndromeGlucocorticoid Receptor

Relacorilant Demonstrates Sustained Efficacy in Hypertension Control for Patients with Cushing’s Syndrome: Results from the Phase 3 GRACE Study

By MedXY|Mar 12, 2026

The Phase 3 GRACE trial demonstrates that relacorilant, a selective glucocorticoid receptor modulator, significantly maintains hypertension control in patients with Cushing’s syndrome without the safety concerns associated with non-selectiv

Beyond the Binary: The Evolving Consensus on the Spectrum of Primary Aldosteronism and Cardiovascular Risk
Cardiologyatrial fibrillationcardiovascular disease

Beyond the Binary: The Evolving Consensus on the Spectrum of Primary Aldosteronism and Cardiovascular Risk

By MedXY|Mar 7, 2026

Recent data from the ARIC study and emerging expert consensus are redefining primary aldosteronism. Rather than a rare, all-or-nothing condition, it is now viewed as a broad spectrum where even subclinical elevations significantly increase

Oxygen-Guided Success: A New Frontier in Adrenal Venous Sampling for Primary Aldosteronism
Diabetes & EndocrinologyAdrenal Venous Samplingendocrinology

Oxygen-Guided Success: A New Frontier in Adrenal Venous Sampling for Primary Aldosteronism

By MedXY|Mar 6, 2026

Researchers have discovered that measuring oxygen partial pressure (pO2) can significantly improve the accuracy and speed of Adrenal Venous Sampling, providing a cost-effective tool for diagnosing Primary Aldosteronism.

Mechanistic Insights into APOL1-Mediated Hypertension: The STING-Endothelin 1 Axis as a Therapeutic Target
Cardiologychronic kidney diseaseHypertension

Mechanistic Insights into APOL1-Mediated Hypertension: The STING-Endothelin 1 Axis as a Therapeutic Target

By MedXY|Mar 2, 2026

This review synthesizes findings on how APOL1 risk variants (G2) drive hypertension and kidney damage through cell-specific mechanisms involving STING activation and endothelin-1 production, offering new precision medicine pathways for high

Intensive Blood Pressure Targets Below 130/80 mmHg Benefit Patients Across the Cardiovascular-Kidney-Metabolic Syndrome Spectrum
Cardiologycardiovascular riskHội Chứng CKM

Intensive Blood Pressure Targets Below 130/80 mmHg Benefit Patients Across the Cardiovascular-Kidney-Metabolic Syndrome Spectrum

By MedXY|Feb 24, 2026

A post hoc analysis of the CRHCP trial demonstrates that intensive blood pressure control (<130/80 mmHg) significantly reduces major adverse **Confirming JSON Structure** I’m now fully focused on creating the JSON object. I’v

Early Life Origins of Hypertension: Longitudinal Evidence That Blood Pressure Tracks from Birth to School Age
CardiologyCardiologyHypertension

Early Life Origins of Hypertension: Longitudinal Evidence That Blood Pressure Tracks from Birth to School Age

By MedXY|Feb 10, 2026

A longitudinal study of the ENVIRONAGE cohort reveals that blood pressure tracks consistently from birth through childhood, with higher neonatal readings significantly increasing the risk of hypertension by age 11, emphasizing the need for

Beyond Weight Loss: CagriSema Emerges as a Potent Antihypertensive in Obesity Management
CardiologyCagriSemaGLP-1 RA

Beyond Weight Loss: CagriSema Emerges as a Potent Antihypertensive in Obesity Management

By MedXY|Feb 2, 2026

The REDEFINE 1 trial demonstrates that CagriSema, a semaglutide/cagrilintide combination, significantly reduces blood pressure in adults with overweight or obesity, even among those with resistant hypertension, while facilitating the reduct

Despite Free Devices and Personalized Support, One-Third of Patients Fail to Engage with Home Blood Pressure Monitoring
CardiologyGiám sát Bệnh nhân Từ xaHypertension

Despite Free Devices and Personalized Support, One-Third of Patients Fail to Engage with Home Blood Pressure Monitoring

By MedXY|Jan 25, 2026

A retrospective cohort study of 3,390 patients reveals that 32.7% showed zero engagement with home blood pressure monitoring (HBPM) despite receiving free equipment and navigator support, highlighting significant behavioral and procedural b

NT-proBNP-Defined Heart Stress: A New Compass for Individualized Blood Pressure Targets in Older Adults?
CardiologyCardiologygeriatrics

NT-proBNP-Defined Heart Stress: A New Compass for Individualized Blood Pressure Targets in Older Adults?

By MedXY|Jan 18, 2026

A post hoc analysis of the ASPREE trial reveals that heart stress, measured by NT-proBNP, significantly alters the relationship between blood pressure and cardiovascular risk in older adults, suggesting a paradigm shift toward biomarker-gui

Prediabetes and Silent Cardiac Injury: A High-Risk Synergy for Heart Failure in Hypertensive Patients
Cardiologybiomarkersheart failure

Prediabetes and Silent Cardiac Injury: A High-Risk Synergy for Heart Failure in Hypertensive Patients

By MedXY|Jan 17, 2026

A post hoc analysis of the SPRINT trial reveals that the coexistence of prediabetes and subclinical myocardial injury or stress significantly escalates heart failure risk in hypertensive adults, suggesting a need for integrated glycemic and

Intensive Blood Pressure Control to <120 mmHg: Holistic Benefits Across Frailty, Quality of Life, and Microvascular Health in the ESPRIT Trial
Cardiologycardiovascular riskFrailty

Intensive Blood Pressure Control to <120 mmHg: Holistic Benefits Across Frailty, Quality of Life, and Microvascular Health in the ESPRIT Trial

By MedXY|Jan 16, 2026

The ESPRIT trial reveals that targeting systolic blood pressure below 120 mmHg significantly reduces cardiovascular events across diverse populations, including frail patients and those with diabetes, while uniquely improving retinal microv

Precision Hypertension Management: Haptoglobin Phenotype Predicts Cardiovascular Benefit from Intensive Blood Pressure Control in Type 2 Diabetes
Cardiologycardiovascular riskHypertension

Precision Hypertension Management: Haptoglobin Phenotype Predicts Cardiovascular Benefit from Intensive Blood Pressure Control in Type 2 Diabetes

By MedXY|Jan 7, 2026

A post-hoc analysis of the ACCORD trial reveals that intensive blood pressure control significantly reduces cardiovascular and stroke risk in haptoglobin 1 allele carriers, but not in those with the Hp2-2 phenotype, suggesting a genotype-dr

Prev
2 / 5
12345
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing &amp; care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities